Ajanta Pharma Ltd Quarterly Results

Gross Sales

1,353.73

1,302.65

1,170.41

1,146.13

1,186.64

Excise Duty

0

0

0

0

0

Net Sales

1,353.73

1,302.65

1,170.41

1,146.13

1,186.64

Other Operating Income

0

0

0

0

0

Other Income

59.34

26.33

18.11

30.44

19.48

Total Income

1,413.07

1,328.98

1,188.52

1,176.57

1,206.12

Total Expenditure

1,025.9

951.3

873.26

825.3

875.47

PBIDT

387.17

377.68

315.26

351.27

330.65

Interest

3.39

5.26

6.07

7.91

6.02

PBDT

383.78

372.42

309.19

343.36

324.63

Depreciation

42.97

41.29

39.78

35.97

34.39

Minority Interest Before NP

0

0

0

0

0

Tax

78.3

73.5

61.96

94.85

76.11

Deferred Tax

2.32

2.29

-17.81

-20.34

-2.35

Reported Profit After Tax

260.19

255.34

225.26

232.88

216.48

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

260.19

255.34

225.26

232.88

216.48

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

260.19

255.34

225.26

232.88

216.48

EPS (Unit Curr.)

20.83

20.44

18

18.6

17.27

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

1,400

Equity

25.07

25.07

25.07

25.07

25.07

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.6

28.99

26.93

30.64

27.86

PBDTM(%)

28.34

28.58

26.41

29.95

27.35

PATM(%)

19.22

19.6

19.24

20.31

18.24